Preparación y modificación genética de primates no humanos tallo hematopoyéticas y células progenitoras

Overview

This protocol outlines the isolation of CD34 + cells from nonhuman primate bone marrow, followed by gene modification using lentiviral vectors. The entire process is designed to prepare these cells for infusion back into the original host, taking approximately 48 hours.

Key Study Components

Area of Science

• Gene therapy
• Cell isolation
• Preclinical models

Background

• Gene-modified cells require thorough testing in preclinical models.
• Nonhuman primate models closely mimic clinical parameters.
• Maintaining relevant cell surface markers is crucial for successful outcomes.
• Supportive treatments in these models should align with those used in human patients.

Purpose of Study

• To isolate and modify CD34 + cells for therapeutic applications.
• To evaluate the efficiency and safety of gene therapy approaches.
• To prepare a viable product for autologous infusion.

Methods Used

• Isolation of bone marrow from healthy nonhuman primates.
• Use of hemolytic buffer for cell incubation.
• Centrifugation to remove cell debris.
• Preparation of cells for gene modification with lentiviral vectors.

Main Results

• Successful isolation of CD34 + cells from bone marrow.
• Effective gene modification using lentiviral vectors.
• Preparation of cells suitable for infusion back into the host.
• Demonstration of the protocol's efficiency and safety.

Conclusions

• This protocol provides a reliable method for isolating and modifying CD34 + cells.
• It supports the advancement of gene therapy in clinical settings.
• Further validation in preclinical models is essential for future applications.

Frequently Asked Questions